Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

After learning you have prediabetes, you may work with your healthcare team to make changes to your eating style, weight ...

A NEW SET OF TARIFFS BY THE TRUMP ADMINISTRATION WILL TAKE EFFECT, AND THEY COULD DRAMATICALLY CHANGE THE WAY YOU GET ...

The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...

DeepSeek claims it can reduce the power consumption of AI, urging the energy industry to rethink future demand estimates.

A thorough examination of modern drugs that target particular receptors and metabolic pathways for glucose and fat metabolism is presented. Recent research has revealed innovative targets and ...

Ozempic, the diabetes medication popularly used as an “off-label” weight-loss drug, has helped thousands shed excess pounds.

New poll shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs if they are ...

A study that reviews the sodium and nutritional content of foods promoted during timeouts and halftime found that adults may ...

More than half of adults with overweight or obesity prescribed a GLP-1 discontinue their drug within 1 year, with discontinuation rates higher for those without type 2 diabetes, researchers reported ...

Fractyl Health is deprioritizing a type 2 diabetes trial in favor of a pivotal study of its endoscopy treatment Revita and ...